DocDollars

F. Hoffmann-La Roche AG

Switzerland · Reporting entity ID 100000005656

Total reported 2019–2025
$214.6M
#56 of 2,960 reporting companies — 0.3% of all reported industry payments
$16.7M in general payments across 7,759 records, plus $197.9M in research funding across 25,913 records.

How it breaks down

General payments $16,707,081
Research funding $197,873,423

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

F. Hoffmann-La Roche AG reported $214.6M to US doctors and teaching hospitals from 2019 to 2025, ranking #56 of 2,960 reporting companies. 92% of that was research funding and 8% general payments such as consulting, speaking, food and travel. 7,759 general payment records and 25,913 research records were filed.

Common questions about F. Hoffmann-La Roche AG

How much has F. Hoffmann-La Roche AG paid US doctors?

F. Hoffmann-La Roche AG reported $214,580,504 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $16,707,081 in general payments, $197,873,423 in research funding.

How does F. Hoffmann-La Roche AG rank among drug and device companies?

It ranks #56 of 2,960 reporting entities by total reported value, about 0.3% of all industry payments in the dataset.

Does a payment from F. Hoffmann-La Roche AG mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.